NCT01602445View on ClinicalTrials.gov

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Venous ThromboembolismDeep-Vein ThrombosisPulmonary EmbolismCancer
Trial Locations (5)

Unknown

Capital Health District Authority, Halifax

CHUM-Notre-Dame Hospital, Montreal

L8L 0A6

Hamilton Health Sciences, Hamilton

N6A 5W9

London Health Science Centre, London

K1H 8L6

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

Ottawa Hospital Research Institute

OTHER